Drugs / Salmeterol/fluticasone propionate
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00370591 | Dec 2002 → Apr 2004 | asthma | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Salmeterol/fluticasone propionate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00370591 ↗ |
| Known as | SFC | “BACKGROUND: This study compared the effect of inhaled fluticasone propionate (FP) with the combination of salmeterol/fluticasone propionate (SFC) on lung function parameters in...” PMID 17629923 ↗ Jul 2007 |
| Route | Inhaled | “Randomised, Double Blind, Parallel Group Study to Assess the Bronchodilative and Bronchoprotective Properties of SERETIDE DISKUS® Inhaler 50/100 mcg Twice Daily vs FLIXOTIDE®...” NCT00370591 ↗ |